377 related articles for article (PubMed ID: 17569228)
1. Chronic inflammatory demyelinating polyneuropathy in a diabetic patient: deterioration after intravenous immunoglobulins treatment and favorable response to steroid treatment.
Pedersen K; Pandolfo M; Mavroudakis N
Acta Neurol Belg; 2007 Mar; 107(1):14-7. PubMed ID: 17569228
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Haq RU; Pendlebury WW; Fries TJ; Tandan R
Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
[TBL] [Abstract][Full Text] [Related]
4. Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP.
Iijima M; Yamamoto M; Hirayama M; Tanaka F; Katsuno M; Mori K; Koike H; Hattori N; Arimura K; Nakagawa M; Yoshikawa H; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakazato M; Nakashima K; Kira J; Kaji R; Oka N; Sobue G
Neurology; 2005 Apr; 64(8):1471-5. PubMed ID: 15851750
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists.
Alshekhlee A; Basiri K; Miles JD; Ahmad SA; Katirji B
Muscle Nerve; 2010 May; 41(5):723-7. PubMed ID: 20405504
[TBL] [Abstract][Full Text] [Related]
6. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
Gorson KC; Natarajan N; Ropper AH; Weinstein R
Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
[TBL] [Abstract][Full Text] [Related]
7. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
Jann S; Beretta S; Bramerio MA
Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
[TBL] [Abstract][Full Text] [Related]
8. Chronic inflammatory demyelinating polyradiculoneuropathy presenting as cauda equina syndrome in a diabetic.
Lai WW; Ubogu EE
J Neurol Sci; 2007 Sep; 260(1-2):267-70. PubMed ID: 17521674
[TBL] [Abstract][Full Text] [Related]
9. IVIg-induced acute polyneuroradiculitis in a patient with CIDP?
Krasenbrink I; Kaps M; Blaes F
Eur J Neurol; 2007 May; 14(5):e9. PubMed ID: 17437603
[No Abstract] [Full Text] [Related]
10. Intravenous immunoglobulin (IVIG) in the treatment of chronic demyelinating polyradiculoneuropathy.
Van den Bergh PY
Acta Neurol Belg; 2001 Sep; 101(3):147-51. PubMed ID: 11817262
[No Abstract] [Full Text] [Related]
11. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
12. [Chronic inflammatory demyelinating polyneuropathy and sarcoidosis: fortuitous association?].
Ducray F; Costedoat-Chalumeau N; Bouhour F; Rousset H; Vial C
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S85-9. PubMed ID: 18087235
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
Lopate G; Pestronk A; Al-Lozi M
Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
[TBL] [Abstract][Full Text] [Related]
14. Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy.
Harbo T; Andersen H; Jakobsen J
Muscle Nerve; 2009 Apr; 39(4):439-47. PubMed ID: 19229876
[TBL] [Abstract][Full Text] [Related]
15. Treatment-responsive pudendal dysfunction in chronic inflammatory demyelinating polyneuropathy.
Bussemaker L; Schelhaas HJ; Overeem S; Hopman WP; Zwarts MJ
Neurology; 2007 Mar; 68(12):957-8. PubMed ID: 17372137
[No Abstract] [Full Text] [Related]
16. Intravenous immunoglobulin for the treatment of diabetic lumbosacral radiculoplexus neuropathy.
Tamburin S; Zanette G
Pain Med; 2009 Nov; 10(8):1476-80. PubMed ID: 19788714
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune hearing loss in chronic inflammatory demyelinating polyneuropathy.
Sivakumar K; Fife TD
Neurology; 2005 Nov; 65(10):1673-4. PubMed ID: 16301508
[No Abstract] [Full Text] [Related]
18. Atypical childhood chronic inflammatory demyelinating polyneuropathy.
Mohamed AR; Rodriguez-Casero MV; Ryan MM
Muscle Nerve; 2010 Aug; 42(2):293-5. PubMed ID: 20589891
[TBL] [Abstract][Full Text] [Related]
19. Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers.
Richez C; Blanco P; Lagueny A; Schaeverbeke T; Dehais J
Neurology; 2005 Apr; 64(8):1468-70. PubMed ID: 15851749
[TBL] [Abstract][Full Text] [Related]
20. [A quadriplegic patient with chronic inflammatory demyelinating polyneuropathy (CIDP) who responded well to corticosteroids and intravenous immunoglobulin therapy].
Fukae J; Okuma Y; Noda K; Fujishima K; Goto K; Mizuno Y
No To Shinkei; 2001 Dec; 53(12):1115-8. PubMed ID: 11806118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]